<DOC>
	<DOCNO>NCT01543854</DOCNO>
	<brief_summary>This study assess hemodynamic effect RLX030 infusion subject acute heart failure . In addition safety effect renal function biomarkers assess .</brief_summary>
	<brief_title>Hemodynamic Responses RLX030 Infusion Subjects With Acute Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients hospitalize require admission hospital management acute heart failure within previous 48 hour . Pulmonary wedge pressure equal to18 mmHg determine right heart catheterization Systolic blood pressure 115 mmHg Significant valvular disease arrythmias Acute coronary syndrome previous 45 day Treatment mechanical support ( intraaortic balloon pump , endotracheal intubation , mechanical ventilation , ventricular assist device ) Impaired renal hepatic function Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>87 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>RLX030</keyword>
	<keyword>Hemodynamics</keyword>
	<keyword>Cardiovascular Diseases</keyword>
</DOC>